Madras High Court Rejects Hyundai Motor’s Plea On ‘Anti-Competitive’ Practices
The Madras High Court has dismissed an appeal filed by Hyundai Motor India Ltd, assailing the CCI's decision to investigate the company for alleged anti-competitive practices related to spare parts sale and after-sale service.
A division bench of justices Huluvadi G Ramesh and RMT Teekaa Raman recently dismissed the appeal filed by the company, challenging the February 4, 2015 order of a single-judge bench of the same court.
The judge had held that a permission to expand the scope of inquiry into the allegations could not be construed as a suo motu initiation of investigation by the director general of the Competition Commission of India.
The matter relates to a complaint lodged with the CCI in 2011 by a New Delhi resident, Shamsher Kataria, alleging anti-competitive practices by three carmakers in the country.
Following a direction, the additional director general of the CCI had in 2011 conducted a probe, which revealed that similar practices were adopted by a few other car manufacturers, and sought the CCI's permission to expand the scope of inquiry into the matter.
Hyundai's had challenged its inclusion claiming that the additional director general did not have the powers to include other companies that were not mentioned in the complaint.
The contention was rejected by the single-judge bench.
Subsequently, the company had filed the writ appeal.
Upholding the order of the single-judge bench, the division bench said, "If the CCI had not issued a direction on April 26, 2011, the director-general could not have proceeded against all other manufacturers.
The direction issued by the commission on April 26, 2011, would tantamount to a direction. Therefore in our considered view, the question of overstepping of jurisdiction does not arise," it added.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.